Aortic Valve Replacement Above the Aortic Annulus (SA-AVR) With the Carpentier-Edwards Magna-Ease Bioprosthesis

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

April 1, 2019

Conditions
Aortic Valve DiseaseProsthesis; Cardiac, Heart, Functional Disturbance as Result
Interventions
PROCEDURE

aortic valve replacement

After median sternotomy, cardiopulmonary bypass (CPB) was established between the ascending aorta and the right atrium. The aorta was cross-clamped and a high potassium warm cardioplegia was infused and repeated every 15 minutes. The aortotomy was made above the sinuses and the aortic valve was removed. The prosthesis was chosen one size larger than the maximal sizer that could be inserted, which was also used to determine the appropriate height for insertion of the sutures along the wall of the non-coronary sinus.

Trial Locations (1)

92350

Hopital Marie Lannelongue, Le Plessis-Robinson

All Listed Sponsors
lead

Centre Chirurgical Marie Lannelongue

OTHER

NCT03976817 - Aortic Valve Replacement Above the Aortic Annulus (SA-AVR) With the Carpentier-Edwards Magna-Ease Bioprosthesis | Biotech Hunter | Biotech Hunter